ES378163A1 - Procedure for the obtaining of 1 - (sec.-amino) - 2 - hidroxi-3- (p- (r-alko) -fenoxi) - propanes. (Machine-translation by Google Translate, not legally binding) - Google Patents

Procedure for the obtaining of 1 - (sec.-amino) - 2 - hidroxi-3- (p- (r-alko) -fenoxi) - propanes. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES378163A1
ES378163A1 ES378163A ES378163A ES378163A1 ES 378163 A1 ES378163 A1 ES 378163A1 ES 378163 A ES378163 A ES 378163A ES 378163 A ES378163 A ES 378163A ES 378163 A1 ES378163 A1 ES 378163A1
Authority
ES
Spain
Prior art keywords
formula
alk
compound
indicated
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES378163A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH519069A external-priority patent/CH529721A/en
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Publication of ES378163A1 publication Critical patent/ES378163A1/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Procedure for obtaining 1- (sec.-amino) -2-hydroxy-3- [p- (R-alk-0) -phenoxy] -propanes of formula **(See formula)** where alk means an alkylene moiety and R means an unsaturated, aliphatic hydrocarbon moiety, R1 means an aliphatic hydrocarbon moiety with up to 15 carbon atoms, which may also be interrupted by heteroatoms, such as oxygen, sulfur or nitrogen, and/or substituted by hydroxy groups, a cycloaliphatic hydrocarbon residue with up to 15 carbon atoms or an araliphatic hydrocarbon residue, optionally substituted, with up to 15 carbon atoms and Ph means a 1,4-phenylene residue, optionally substituted, and their products condensation with aldehydes or ketones, characterized in that a compound of the formula **(See formula)** where R, alk and Ph have the indicated meanings, X'' means the hydroxyl group and X'means an esterified hydroxyl group, capable of reaction, or X''and X' together form an epoxy group, reacted with an amine of the formula R1-NH2, in which R1 has the indicated meaning, or a condensation product thereof with an aldehyde or ketone or in a compound of the formula **(See formula)** in which R, alk and Ph have the indicated meanings, or in a condensation product thereof with an aldehyde or a ketone, the remainder or a phenol of the formula is introduced R-alk-O-Ph-OH (VI) in which R, alk and Ph have the indicated meanings, is reacted with a compound of the formula **(See formula)** where it has the indicated meaning, X'' means the hydroxyl groups and X'an esterified hydroxyl group, capable of reaction, or X''and X' together form an epoxy group, or with a condensation product of a compound, where X'' means the hydroxyl group, with an aldehyde or ketone, or in a compound of formula **(See formula)** in which Ph and R1 have the indicated meanings, or in a condensation product thereof with an aldehyde or ketone, the phenolic hydroxyl group is replaced in the usual way by the R-alk moiety, where R and alk have the above indicated meaning, or in 1- (R1-amino) -2-hydroxy-propane, which in position 3 carries the rest of the formula R-alk-O-Ph-O- in which R, alk, Ph and R1 have the indicated meanings, and that in the nitrogen atom and/or in the 2-hydroxy group it carries a moiety dissociable by hydrolysis, it dissociates, or a compound of formula **(See formula)** in which R, Ph and alk have the meanings indicated above, and Y means a residue of the formula -CH2-N = R1'(a) or -CH = N-R1 (b) in which it is a bivalent residue in a carbon atom of the class of R1, the compound of formula XII being able to be presented also in its tautomeric form, a compound of formula **(See formula)** in which R, alk and Ph have the indicated meanings and is a bivalent residue in a carbon atom of the class of R1, it is reduced and, if desired, the compounds obtained of formula I are transformed by reaction with aldehydes or ketones or carbonyl derivatives thereof, capable of reaction, in the corresponding oxazolidines, or the oxazolidines obtained are hydrolyzed to the corresponding compounds of formula I and/or the mixtures of isomers, if appropriate obtained, are separated and/or the racemates obtained are dissociated in the optical antipodes, and/or the salts obtained are transformed into the free bases or the free bases obtained in their salts. (Machine-translation by Google Translate, not legally binding)
ES378163A 1969-04-03 1970-04-02 Procedure for the obtaining of 1 - (sec.-amino) - 2 - hidroxi-3- (p- (r-alko) -fenoxi) - propanes. (Machine-translation by Google Translate, not legally binding) Expired ES378163A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH519069A CH529721A (en) 1969-04-03 1969-04-03 Unsatd. amine(s), tranquillisers and vasodilators
CH545069 1969-04-09
CH228070 1970-02-17

Publications (1)

Publication Number Publication Date
ES378163A1 true ES378163A1 (en) 1973-08-01

Family

ID=27173592

Family Applications (1)

Application Number Title Priority Date Filing Date
ES378163A Expired ES378163A1 (en) 1969-04-03 1970-04-02 Procedure for the obtaining of 1 - (sec.-amino) - 2 - hidroxi-3- (p- (r-alko) -fenoxi) - propanes. (Machine-translation by Google Translate, not legally binding)

Country Status (7)

Country Link
AU (1) AU1320070A (en)
DE (1) DE2014346A1 (en)
ES (1) ES378163A1 (en)
FR (1) FR2038200A1 (en)
GB (1) GB1290593A (en)
NL (1) NL7004728A (en)
OA (1) OA03248A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3205457A1 (en) * 1982-02-16 1983-08-25 Merck Patent Gmbh, 6100 Darmstadt OXAZOLIDIN-2-ONE

Also Published As

Publication number Publication date
AU1320070A (en) 1971-10-07
GB1290593A (en) 1972-09-27
FR2038200A1 (en) 1971-01-08
OA03248A (en) 1970-12-15
NL7004728A (en) 1970-10-06
DE2014346A1 (en) 1970-10-08

Similar Documents

Publication Publication Date Title
ES419936A1 (en) 1-hydroxy-1-((4'-hydroxy-3'aminosulfonamido)-phenyl)-2-amino-ethanes and salts
ES369570A1 (en) New thiadiazolyl-ureas, their production and composition containing same
ES378163A1 (en) Procedure for the obtaining of 1 - (sec.-amino) - 2 - hidroxi-3- (p- (r-alko) -fenoxi) - propanes. (Machine-translation by Google Translate, not legally binding)
ES422301A1 (en) Amines and processes for their manufacture
GB1350883A (en) Bis-stilbene compounds
GB1091394A (en) Novel process for the preparation of unsaturated cyclic ketones
ES452616A1 (en) Derivatives of 1-(disubstituted phenoxy)-3-amino-2-hydroxypropanes
ES394256A1 (en) Process for the preparation of 4-oxocapronitrile
ES8300217A1 (en) Apparatus for recording and/or reproducing signals on a magnetic tape.
ES421417A1 (en) Method of inhibiting a colour-forming reaction
ES436218A1 (en) Phenoxyalkanol derivatives and a process for their preparation
GB1396875A (en) Hydroxyaryl carboxylic acids and esters thereof and their use as antioxidants
ES274334A1 (en) Procedure for the preparation of new 1,4-benzodioxan compounds (Machine-translation by Google Translate, not legally binding)
ES387248A1 (en) Procedure for preparing a compound with therapeutic activity. (Machine-translation by Google Translate, not legally binding)
ES416561A1 (en) 1,2,4-oxadiazole derivatives
ES402224A1 (en) Process for the preparation of alpha-anilinocarboxylic esters or nitriles
ES384923A1 (en) Procedure for the preparation by synthesis, of eteres of beta-hydroxycetons. (Machine-translation by Google Translate, not legally binding)
ES386626A3 (en) Procedure for the obtaining of fenoxialquilaminas. (Machine-translation by Google Translate, not legally binding)
ES405484A1 (en) Derivatives of 1-phenoxy-3-amino-propan-2-ol and process for their producrion
ES405438A1 (en) 2-acyl-5-nitrothiazole derivatives
ES444005A2 (en) Salts of 2-alkylthiazole-5-methanol derivatives
ES243436A2 (en) A procedure for the manufacture of 4,4-dioxy-difenil-piridil-metanos (Machine-translation by Google Translate, not legally binding)
ES278068A1 (en) Method for the preparation of a compound of formula (Machine-translation by Google Translate, not legally binding)
ES234444A1 (en) New procedure for the preparation of alcoiloxy and aralcoiloximethylpolisiloxanes (Machine-translation by Google Translate, not legally binding)
ES266780A1 (en) Procedure for the obtaining of 4,4'-dihydroxy-2 '' - amino-trifenylmethane and its derivatives (Machine-translation by Google Translate, not legally binding)